Tenon Medical Inc's Q4 Earnings Call: SImmetry+ Launch Timeline and Revenue Run Rate Expectations Diverge

Date of Call: Mar 19, 2026

Financials Results

• Revenue: $1.5 million in Q4, up 92% YOY; $3.9 million for full year 2025, up 20% YOY
• EPS: Net loss of $0.29 per share in Q4 2025, improved from a net loss of $0.98 per share in Q4 2024; net loss of $1.70 per share for full year 2025, improved from a net loss of $11.26 per share in the prior year
• Gross Margin: 69% of revenue in Q4 2025, up 23 percentage points from 46% in the prior-year quarter; 60% for full year 2025, up 8 percentage points from 52% in the prior year

Business Commentary:

Revenue Growth:

• Tenon Medical reported record full-year revenue of $3.9 million, a 20% increase compared to 2024, with fourth quarter revenue of $1.5 million, representing a 92% increase over the prior year period.
• The growth was driven by increased surgical procedures across both the Catamaran and SImmetry+ platforms, primarily due to new physician users.

Gross Margin Improvement:

• The company’s gross profit for the fourth quarter was $1 million, or 69% of revenue, compared to $0.4 million or 46% of revenue in the prior-year quarter, indicating an 188% increase and a 23 percentage point improvement in gross margin.
• This improvement was attributed to higher revenue and the further absorption of fixed costs within the cost of goods sold.

Operating Expenses and Cash Position:

• Operating expenses totaled $3.9 million for the fourth quarter of 2025, up from $3.5 million in the prior year quarter, while the company ended the quarter with $3.8 million in cash and cash equivalents.
• The increase in operating expenses was primarily due to higher variable expenses within sales and marketing driven by increased revenue, whereas the cash position reflects the company's financial flexibility post recent financings.

Product Expansion and Market Position:

• Tenon Medical received FDA 510(k) clearance for the next generation SImmetry+ SI joint fusion system, enhancing its product portfolio and competitive position.
• This milestone, alongside strong clinical engagement and financial strengthenings, is expected to drive broader commercial uptake and deeper physician engagement.

Sentiment Analysis:

Overall Tone: Positive

• CEO states results 'demonstrate continued momentum' and are a 'pivotal inflection point'. Management highlights 'record top-line performance', 'strong second-half momentum', 'FDA 510(k) clearance', and being 'well-positioned to accelerate adoption'. Expresses 'confidence that we can meet and exceed expectations in 2026' and notes 'strengthened our balance sheet' and 'strong platform for continued execution'.

Q&A:

• Question from Scott Henry (Alliance Global Partners): How representative is the Q4 operating expense rate for 2026, and should we consider the $3.9 million as a baseline?
  Response: Yes, Q4 operating expense is a better baseline for 2026 due to higher integration costs falling out and variable expenses increasing with revenue.

• Question from Scott Henry (Alliance Global Partners): How should we think about 2026 revenue relative to a $6 million annualized run rate, and what is the key driver for growth?
  Response: Momentum from the back half of 2025 is expected to continue, with higher Q4 typically seeing higher revenue. Growth will be driven by commercial expansion and execution across a multi-product portfolio.

• Question from Anthony Vendetti (Maxim Group): How is the launch of SImmetry+ helping gain access to more physicians or medical centers?
  Response: The broader multi-product portfolio (including SImmetry+) provides more surgical approach options for physicians, opening doors and encouraging adoption, with positive initial feedback on the implant and instrument set.

Contradiction Point 1

Revenue Run Rate Expectations for Q1 2026

Contradiction in expectations for the continuity of the Q4 revenue run rate into Q1 2026.

Scott Henry (Alliance Global Partners) - Scott Henry (Alliance Global Partners)

2025Q4: The $6 million run rate is expected to carry into Q1. - [Kevin Williamson](CFO)

How representative is the Q4 $3.9 million operating expense for 2026, and how should we model 2026 revenue (especially Q1) relative to the $6 million annualized run rate? - Scott Henry (Alliance Global Partners)

20251114-2025 Q3: The SImmetry+ alpha launch is upcoming and will begin contributing revenue soon. - [Kevin Williamson](CFO)

Contradiction Point 2

SImmetry+ Launch Timeline and Status

Contradiction in describing the SImmetry+ launch as both successful and still upcoming.

Anthony Vendetti (Maxim Group) - Anthony Vendetti (Maxim Group)

2025Q4: The SImmetry+ launch has been successful, with extremely positive physician reaction. - [Steve Foster](CEO)

How is the SImmetry+ launch progressing, and is the broader portfolio expanding access to physicians/centers? - Scott Henry (Alliance Global Partners)

20251114-2025 Q3: The SImmetry+ alpha launch is upcoming and will begin contributing revenue soon. - [Kevin Williamson](CFO)

Contradiction Point 3

Catamaran Revenue Recovery Timeline

Contradiction on when Catamaran revenue is expected to return to prior levels.

Scott Henry, how did Alliance Global Partners perform in the latest quarter? - Scott Henry (Alliance Global Partners)

2025Q4: The momentum built in the back half of 2025 is expected to continue... The $6 million run rate is expected to carry into Q1. - [Kevin Williamson](CFO)

How representative is the Q4 $3.9 million operating expense for 2026, and what is the expected 2026 revenue trajectory relative to the Q4 $6 million annualized run rate, including Q1 expectations and key growth drivers? - Scott Robert Henry (Alliance Global Partners)

2025Q2: Catamaran revenue is expected to return to prior levels in Q3 and benefit from the additional revenue from Symmetry. - [Kevin Williamson](CFO)

Contradiction Point 4

Timing and Impact of Reimbursement Coding Clarity

Inconsistent portrayal of when coding clarity will benefit revenue.

Scott Henry (Alliance Global Partners) - Scott Henry (Alliance Global Partners)

2025Q4: Momentum built in the back half of 2025 is expected to continue... The $6 million run rate is expected to carry into Q1. - [Kevin Williamson](CFO)

How should we interpret the Q4 operating expense of $3.9 million and the $6 million annualized run rate in relation to 2026 financial expectations? - Scott Henry (Alliance Global Partners)

2025Q1: Expected improvements in the reimbursement environment (coding clarity for SI joint fusion from a 2026 update) will... progressively improve. - [Steve Foster](CEO)

Contradiction Point 5

Characterization of Catamaran SE Platform Launch Impact

Contradictory labels for the SE launch's role in growth.

What are Alliance Global Partners' key financial highlights for the quarter? - Scott Henry (Alliance Global Partners)

2025Q4: The company is excited about strong adoption momentum... The key driver for 2026 growth is commercial expansion and execution with a multi-product portfolio. - [Steve Foster](CEO)

Okay, let's see. The user wants me to rewrite the input into a concise earnings-call question. The input is "What is the key driver for 2026 revenue growth?" First, I need to check the rules. The output must be exactly one line, only the final question, end with a question mark if possible. No explanations or meta text. If the input isn't a question or is too vague, output it as-is.The input is already a question. The task is to make it more concise. "Key driver" could maybe be simplified. Maybe "main factor" instead? Let me think. "What is the main factor for 2026 revenue growth?" But the original uses "key driver," which is common in business contexts. Maybe "primary driver" is better? Or perhaps "What's the main driver of 2026 revenue growth?" But the user wants it concise. The original is already pretty concise. Maybe it's already the best version. The user might not want to change "key driver" because that's the correct term. Let me check again. The original is a clear question, specific, and meets the criteria. Maybe no rewrite is needed. Wait, the instruction says if it's already a clear question, output as-is. But the user says "rewrite the input into one concise..." So maybe they expect a slight rephrase. But if the input is already a clear question, according to the rules, if it's already a question and has enough info, output as-is. Wait, the rules say: "If the input is NOT a question, is too vague, or lacks enough information to form a clear earnings-call question, output the input EXACTLY as-is, with no modification." So if the input is a clear question, we can rewrite it. Wait, no. Wait, the instruction says "If the input is NOT a question... output as-is. If it is a question, rewrite into a concise one." Wait, no. The user says "Rewrite the input into ONE concise earnings-call question." So regardless of whether it's a question or not, they want a rewrite. But the rules say that if it's not a question, too vague, etc., output as-is. So in this case, the input is a clear question. So we can proceed to rewrite it. Let me think again. The original is "What is the key driver for 2026 revenue growth?" Maybe make it more direct. "What's the main driver of 2026 revenue growth?" But "key driver" is already concise. Maybe "What is the primary factor driving 2026 revenue growth?" But that's longer. The original is concise. Maybe the original is already the best version. But the user wants it rewritten. Hmm. Maybe the user wants to make it even more concise. Let me check synonyms. "Driver" can be "factor" or "contributor." But "key driver" is standard. Maybe the answer is to leave it as-is. Wait, but the input is already a clear question. The rules say if it's a clear question, do we need to rewrite? The user says "rewrite the input into..." so even if it's a question, we need to rephrase. But maybe the input is already the best possible question. Let me check the rules again. The output must end with "?" if a rewrite is possible. So if a rewrite is possible, end with "?". If not, output as-is. Wait, the rule says: "The output MUST end with "?" IF a rewrite is possible." So if the input is a question and can be rewritten, then output the rewritten version with "?", else output as-is. So in this case, since the input is a question and can be rewritten, we have to rewrite. But how? Let me think. Maybe "What's the key driver for 2026 revenue growth?" but "What's" is informal. The original uses "What is". Maybe "What is the primary driver for 2026 revenue growth?" Or maybe "What is the main factor driving 2026 revenue growth?" But the original is already concise. Maybe the original is the best. But the user wants a rewrite. Hmm. Alternatively, perhaps the original is acceptable. Wait, the user says "rewrite the input into ONE concise earnings-call question." So maybe the original is already a concise question, so output as-is. But according to the rules, if it's a clear question, do we need to rewrite? The rules state that if the input is NOT a question, etc., output as-is. So if it is a question, we need to try to rewrite. But maybe the original is already the best. Maybe the answer is the same as input. Wait, but the user wants a rewrite. Maybe the user wants to make it more concise. Let me check the original: "What is - Scott Henry (Alliance Global Partners)

2025Q1: The launch of the Catamaran SE platform in mid-2025 is viewed as an inflection point. - [Steve Foster](CEO)